Moreover, some cancer therapies, such as chemotherapy, radiotherapy, and targeted therapy, seem to be affected when ISG15 levels are deregulated, suggesting that ISG15 may be implicated in the response to cancer therapies (Table 5). The gene discussed is ISG15; the disease is cancer.